PROMETHEUS BIOSCIENCES, INC. Comprehensive Income
PROMETHEUS BIOSCIENCES, INC. reported Comprehensive Income of -$40.68 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$40.68M.
- PROMETHEUS BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$38.74M.
- PROMETHEUS BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$37.42M.
- PROMETHEUS BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was -$33.96M.
- PROMETHEUS BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$142.18M.
- PROMETHEUS BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$90.19M.
- PROMETHEUS BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$37.14M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$40.68M 10-Q · filed 2023-05-09 | -$79.42M derived: sum of 2 quarters · filed 2023-05-09 | -$116.84M derived: sum of 3 quarters · filed 2023-05-09 | -$150.79M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | -$38.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$76.16M derived: sum of 2 quarters · filed 2023-02-28 | -$110.11M derived: sum of 3 quarters · filed 2023-02-28 | -$142.18M 10-K · filed 2023-02-28 |
| 2022-09-30 | -$37.42M 10-Q · filed 2022-11-09 | -$71.37M derived: sum of 2 quarters · filed 2022-11-09 | -$103.44M 10-Q · filed 2022-11-09 | -$133.36M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | -$33.96M 10-Q · filed 2022-08-11 | -$66.02M 10-Q · filed 2022-08-11 | -$95.94M derived: sum of 3 quarters · filed 2023-05-09 | -$123.27M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | -$32.07M 10-Q · filed 2023-05-09 | -$61.98M derived: sum of 2 quarters · filed 2023-05-09 | -$89.32M derived: sum of 3 quarters · filed 2023-05-09 | -$108.32M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$29.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$57.25M derived: sum of 2 quarters · filed 2023-02-28 | -$76.25M derived: sum of 3 quarters · filed 2023-02-28 | -$90.19M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$27.33M 10-Q · filed 2022-11-09 | -$46.33M derived: sum of 2 quarters · filed 2022-11-09 | -$60.28M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$19.00M 10-Q · filed 2022-08-11 | -$32.94M 10-Q · filed 2022-08-11 | ||
| 2020-12-31 | -$37.14M 10-K · filed 2023-02-28 |